慢性肢体威胁性缺血患者直接与间接血管腔内及外科血运重建后的结局:一项荟萃分析与系统评价
该系统评价与荟萃分析比较慢性肢体威胁性缺血患者接受直接与间接血管体引导血运重建的临床结局差异,纳入9篇比较性研究。直接血运重建与改善的无截肢生存、创面愈合及总体生存相关,创面愈合时间与血运重建方式无关。
要点
- 创面愈合时间与直接或间接血运重建均无关(SMD=-2.15,P=0.11)。
核心结论
- 直接血运重建与慢性肢体威胁性缺血患者改善的无截肢生存、总体生存和创面愈合相关。
研究设计与样本
- 系统评价与荟萃分析,检索PubMed、Embase/Medline、Cochrane reviews和Web of Science截至2023年9月的英文文献。
- 纳入比较直接与间接血管体引导血运重建在慢性肢体威胁性缺血中临床结局的比较性研究,包括回顾性、前瞻性和随机对照试验。
- 共分析9篇文章的数据,采用随机效应模型计算关联度量,用Begg检验和Egger检验评估发表偏倚,用I²计算异质性。
主要发现
- 创面愈合时间与直接或间接血运重建均无关(SMD=-2.15,P=0.11)。
- 根据RoB 2.0工具,所有研究偏倚风险低。
临床怎么用
- 作者在临床影响中指出,保肢对预防死亡和维持独立生活至关重要。
- 作者指出,血管体引导血运重建对慢性肢体威胁性缺血的获益仍存争议。
- 作者指出,当前发现提示直接血管体引导干预降低截肢率并改善生存;但许多试验未涉及创面护理管理所需的多因素方法。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The purpose of this review and meta-analysis is to determine the clinical outcome differences between patients with chronic limb-threatening ischemia who underwent direct versus indirect angiosome revascularization using either the surgical or endovascular approach. MATERIALS AND METHODS: The data sources used for article selection included PubMed, Embase/Medline, Cochrane reviews, and Web of Science (All studies were in English and included up to September 2023). All articles included were comparative in design, including retrospective, prospective, and randomized controlled trials that compared the clinical outcomes between direct and indirect angiosome-guided revascularization in chronic limb-threatening ischemia. A random-effects model was used to determine the measure of association between direct revascularization and amputation-free survival, wound healing, and overall survival. Publication bias was assessed with both Begg's and Egger's test, and heterogeneity was calculated using an I2. RESULTS: Data from 9 articles were analyzed and reported in this review. Direct revascularization was associated with improved amputation-free survival (odds ratio [OR]=2.632, confidence interval [CI]: 1.625, 4.265), binary wound healing (OR=2.262, CI: 1.518, 3.372), and overall survival (OR=1.757, CI: 1.176, 2.625). Time until wound healed was not associated with either direct or indirect revascularization (Standard Mean Difference [SMD]=-2.15, p=0.11). There was a low risk of bias across all studies according to the RoB 2.0 tool. CONCLUSION: Direct revascularization is associated with improved amputation-free survival, overall survival, and wound healing in chronic limb-threatening ischemic patients compared to the indirect approach.Clinical ImpactPreservation of the lower extremity is critical for preventing mortality and maintaining independence. The benefit of angiosome-guided revascularization for chronic limb-threatening ischemia remains controversial. The authors of this article aim to review the current literature and compare direct and indirect angiosome-guided intervention for preserving the lower extremity. Current findings suggest direct angiosome-guided intervention reduces amputation rates and improves survival; however, many trials neglect to address the multifactorial approach needed in wound care management.
引用
- Tarricone A, Gee A, de la Mata K, et al. Outcomes for Patients With Chronic Limb-Threatening Ischemia After Direct and Indirect Endovascular and Surgical Revascularization: A Meta-Analysis and Systematic Review. J Endovasc Ther. 2024. PMID: 38687701. doi:10.1177/15266028241248524
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。